Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

European Heart Journal

Volumn 21, Issue 18, 2000, Pages 1502-1513

  Alpert, J S ^a   Antman, E ^a   Apple, F ^a   Armstrong, P W ^a   Bassand, J P ^a   De Luna, A B ^a   Beller, G ^a   Breithardt, G ^a   Chaitman, B R ^a   Clemmensen, P ^a   Falk, E ^a   Fishbein, M C ^a   Galvani, M ^a   Garson A , Jr ^a   Grines, C ^a   Hamm, C ^a   Nauheim, B ^a   Hoppe, U ^a   Jaffe, A ^a   Katus, H ^a   Kjeksus, J ^a   Klein, W ^a   Klootwijk, P ^a   Lenfant, C ^a   Levy, D ^a   Levy, R I ^a   Luepker, R ^a   Marcus, F ^a   Naslund, U ^a   Ohman, M ^a   Pahlm, O ^a   Poole Wilson, P ^a   Popp, R ^a   Pyorala, K ^a   Ravkilde, J ^a   Rehnquist, N ^a   Roberts, W ^a   Roberts, R ^a   Roelandt, J ^a   Ryden, L ^a   Sans, S ^a   Simoons, M L ^a   Thygesen, K ^a   Tunstall Pedoe, H ^a   Underwood, R ^a   Uretsky, B F ^a   Van de Werf, F ^a   Voipio Pulkki, L M ^a   Wagner, G ^a   Wallentin, L ^a   Wijns, W ^a   Wood, D ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY CATHETERIZATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEALTH CARE POLICY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART SURGERY; HUMAN; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; CLINICAL TRIALS; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; PUBLIC POLICY;

EID: 0033822124     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2305     Document Type: Review

References (57)

1. In situ apoptosis assay for the detection of early acute myocardial infarction
2. Modulation of the myocardial response to injury
3. The histopathologic evolution of myocardial infarction
4. Factors involved in salvaging ischemic myocardium: Effect of reperfusion of arterial blood
5. Effect of reperfusion late in the phase of reversible ischemic injury: Changes in cell volume, electrolytes, metabolites, and ultrastructure
6. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
7. The speed of healing of myocardial infarction: A study of the pathologic anatomy in 72 cases
8. Apoptosis in human acute myocardial infarction
9. Association between minor elevations of creatine-kinase-MB and mortality in patients with acute coronary syndromes without ST-segment elevation
10. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T
11. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
12. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I
13. Clinical and analytical standardization issues confronting cardiac troponin I
14. Tissue specificity of cardiac troponin I, cardiac troponin T, and creatine kinase MB
15. Myonecrosis after revascularization procedures
16. Troponin T or troponin I or CK-MB (or none?)
17. Can troponin T replace CK-MB mass as 'gold standard' for acute myocardial infarction ('AMI')?
18. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
19. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
20. The prognostic value of serum troponin T in unstable angina
21. Characteristics and consequences of myocardial infarction following percutaneous coronary intervention: Insights from the Coronary Angioplasty Versus Excisional Atherectomomy Trial (CAVEAT)
22. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma
23. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
24. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
25. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
26. Diagnostic performance and prognostic values of serum troponin T in suspected acute myocardial infarction
27. Clinical outcomes after detection of elevated enzymes in patients undergoing percutaneous intervention: IMPACT-II trial (Integrilin [eptifibatide] to Minimize Platelet Aggregation and Coronary Thrombosis-II)
28. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations use of cardiac markers in coronary artery disease
29. Diagnostic marker cooperative study for the diagnosis of myocardial infarction
30. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts
31. Myocardial infarction: Myocardial injury, and myocardial ischemia
32. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes
33. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction
34. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle
35. The Minnesota Code Manual of Electrocardiographic Findings: Standards and procedures for measurement and classification
36. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression
37. The Selvester QRS scoring system for estimating myocardial infarct size: The development and application of the system
38. Assessment of myocardial viability
39. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction
40. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes
41. A rapid diagnostic and treatment center for patients with chest pain in the emergency department
42. Two-dimensional echocardiography and infarct size: Relationship of regional wall motion and thickening to the extent of myocardial function in the dog
43. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect
44. Quantification of left ventricular function with thallium-201 and technetium-99m sestamibi myocardial gated SPECT
45. Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room
46. Importance to two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms
47. Ultrasonic tissue characterization for diagnosis of acute myocardial infarction in the coronary care unit
48. Comprehensive strategy for the evaluation and triage of the chest pain patients
49. The effects of diagnostic criteria on trends in coronary heart disease morbidity: The Minnesota Heart Survey
50. International diagnostic criteria for acute myocardial infarction and acute stroke
51. Recent trends in acute coronary heart disease - Mortality, morbidity, medical care and risk factors
52. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
53. Comparability of criteria and methods in the epidemiology of cardiovascular disease: Report of a survey
54. Nomenclature and criteria for diagnosis of ischemic heart disease
55. Epidemiological classification of acute myocardial infarction: Time for a change?